Highlights
1 patent
About
COVID-19 Therapy
Airtonics Health uses nanosilver with specific physicochemical parameters for a minimally invasive method of inactivating SARS-CoV-2 coronavirus at an early stage of infection.
Identity
| Name | Airtonics Health |
|---|---|
| Slug | vytonic-medical |
| Former names | Vytonic Medical |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KG55o8JDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Aug 2025 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Tel Aviv, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business models
B2B
Tags
medical-technologieshome-careminimally-invasiverespiratoryhealthcare-providerstherapeuticstreatments
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}